Mount Sinai Health System · 2 hours ago
Postdoctoral Fellow-MSH-30035-388
Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, and they are seeking a Postdoctoral Fellow in the Neuroscience department. The role involves conducting research on substance use disorders, including performing drug IVSA experiments, genomic sequencing, and stereotaxic surgeries to explore the molecular mechanisms involved.
Health CareHospitalMedical
Responsibilities
The candidate will perform volitional drug (e.g., cocaine, heroin) IVSA experiments in mice and rats to explore the molecular underpinnings of substance used disorders
Beyond drug self-administration behavioral experiments, the candidate will perform genomic sequencing (including single-cell sequencing), proteomics, metabolomics, and other relevant methodologies
They will also perform stereotaxic surgeries to assess the impact of viral mediated gene therapy on SUD-related phenotypes
Drug IVSA, behavioral analysis of SUD-related phenotypes, genomic sequencing, basic molecular & biochemical methodologies
Qualification
Required
PhD
0 years of postdoctoral experience required
Company
Mount Sinai Health System
Mount Sinai Health System delivers integrated medical care, research, and medical education through its network.
H1B Sponsorship
Mount Sinai Health System has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (2)
2024 (3)
2023 (26)
2022 (20)
2021 (6)
2020 (20)
Funding
Current Stage
Late StageTotal Funding
$41.9MKey Investors
National Institutes of HealthHearst Health Prize.Multiple Myeloma Research Foundation
2024-11-11Grant· $7M
2024-06-06Grant· $0.1M
2023-11-02Grant· $7M
Leadership Team
Recent News
The Times Of Israel
2025-11-24
2025-11-14
Company data provided by crunchbase